Testing effectiveness (Phase 2)Study completedNCT00620217
What this trial is testing
Angiogenesis Using VEGF-A165/bFGF Plasmid Delivered Percutaneously in No-option CAD Patients; a Controlled Trial
Who this might be right for
Coronary Artery Disease
National Institute of Cardiology, Warsaw, Poland 52